Biohaven Ltd. (BHVN) is a publicly traded Healthcare sector company. As of August 25, 2026, BHVN trades at $13.68 with a market cap of $2.09B and a P/E ratio of -0.92. BHVN moved -1.44% today. Year to date, BHVN is +21.17%; over the trailing twelve months it is -12.36%. Its 52-week range spans $7.48 to $44.28. Analyst consensus is strong buy with an average price target of $20.00. Rallies surfaces BHVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BHVN, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $13.68 |
| Market Cap | $2.09B |
| P/E Ratio | -0.92 |
| EPS | $-14.83 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.28 |
| 52-Week Low | $7.48 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $859.68M |
| Net Income | $-930.69M |
| Gross Margin | 85.63% |
13 analysts cover BHVN: 0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.00.